⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL254059 | 0.59 | — | — | |
| SCHEMBL17012264 | 0.59 | — | — | |
| Dimethylamine SCHEMBL27330962 | 0.59 | — | — | |
| SCHEMBL10440598 | 0.56 | — | — | |
| SCHEMBL20259347 | 0.56 | — | — | |
| SCHEMBL15576723 | 0.56 | — | — | |
| SCHEMBL24482768 | 0.56 | — | — | |
| SCHEMBL22065492 | 0.56 | — | — | |
| Dimethylamine SCHEMBL4910341 | 0.54 | — | — | |
| SCHEMBL2709130 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192607-A1 | TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2022169218-A1 | METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION | 주식회사 엘지화학 | 2022-08-11 | — | — | WO | disclosed |
| US-20220215799-A1 | DISPLAY PANEL, DRIVING METHOD THEREOF AND DISPLAY DEVICE | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2022-07-07 | — | — | US | disclosed |